EP13.01-11 Study of NLI Use in the First Line of Atezolizumab Plus Chemotherapy

Autor: Cruz, P., Riesco Montes, B., Fernandez Franco, L., Falagan, S., Chara, L.E., Gutierrez-Sainz, L., Simon Alonso, S., Cerezo, S., Higuera, O., Villamayor, J., Galan Moral, R., Villa, J.C., Alvarez Cabellos, R., Lopez Bajo, R., Portela, J., Serrano, M., Santos Rodriguez, A.K., Muñoz-Rodriguez, J.R.
Zdroj: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S686-S687
Databáze: ScienceDirect